SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-06-074432
Filing Date
2006-04-06
Accepted
2006-04-06 10:10:45
Documents
2
Period of Report
2006-05-17
Effectiveness Date
2006-04-06

Document Format Files

Seq Description Document Type Size
1 NOTICE & PROXY STATEMENT ddef14a.htm DEF 14A 261906
2 GRAPHIC g85232g89h12.jpg GRAPHIC 58965
  Complete submission text file 0001193125-06-074432.txt   344751
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27570 | Film No.: 06743939
SIC: 8731 Services-Commercial Physical & Biological Research